Eradication of Helicobacter pylori has no effect on gastric acidity in duodenal ulcer patients - Evaluation of 24-h pH monitoring

I. Rácz, Andrea Szabó, Mihály Csöndes, Gyula Pécsi, Mária Goda

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

It is accepted that eradication of Helicobacter pylori leads to healing of chronic active gastritis facilitates ulcer healing and prevents ulcer recurrence in duodenal ulcer (DU) patients. However, it is not entirely known whether the eradication of the bacteria normalizes gastric acid secretion and abolishes dyspeptic symptoms after ulcer healing. This study was aimed to evaluate the intragastric acidity and dyspeptic complaints before, and 3 months after, eradication in 18 endoscopically proven H. pylori positive DU patients. Gastric pH was measured by 24-h continuous intraluminal recording, serum gastrin measurements and Congo-red tests were also performed. Dyspeptic complaints and antacid consumptions were recorded in diary cards, antisecretory therapy was not allowed after the cessation of eradication therapy. Endoscopy, H. pylori status and Congo-red tests were controlled at the 6th and 12th week, while pH measurements and serum gastrin tests were performed at inclusion and 3 months later. Three patients dropped out and in 14 out of the remaining subjects healing of DUs and successful eradications were achieved by the 6th and 12th week controls. The 24-h median pH and the percentage of 24-h pH readings under pH 3 were not changing significantly by the 3-month controls (from 1.9±0.5 to 1.8±0.4 and from 52.6±5.5% to 58.6±5%, respectively). Similary, no significant changes were observed in serum gastrin levels and dyspeptic symptom scores (from 72±7 pg/ml to 56.7±8 pg/ml and from 2.69±0.4 to 1.26±0.3, respectively). The antacid consumption was almost stable when compared with the pre- and post-eradication periods. It was concluded that despite successful H. pylori eradication and healing of DU, intragastric acidity does not change significantly at least 3 months after the therapy. The persisting dyspeptic symptoms and the need for antacid consumption suggest that some healed ulcer patients require antisecretory therapy in the post-eradication period.

Original languageEnglish
Pages (from-to)469-475
Number of pages7
JournalJournal of Physiology Paris
Volume95
Issue number1-6
DOIs
Publication statusPublished - 2001

Fingerprint

Duodenal Ulcer
Helicobacter pylori
Stomach
Antacids
Ulcer
Gastrins
Congo Red
Serum
Gastric Acid
Gastritis
Therapeutics
Endoscopy
Reading
Bacteria
Recurrence

Keywords

  • Duodenal ulcer
  • Dyspeptic symptoms
  • Eradication therapy
  • Gastric acidity
  • Helicobacter pylori

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology (medical)

Cite this

Eradication of Helicobacter pylori has no effect on gastric acidity in duodenal ulcer patients - Evaluation of 24-h pH monitoring. / Rácz, I.; Szabó, Andrea; Csöndes, Mihály; Pécsi, Gyula; Goda, Mária.

In: Journal of Physiology Paris, Vol. 95, No. 1-6, 2001, p. 469-475.

Research output: Contribution to journalArticle

Rácz, I. ; Szabó, Andrea ; Csöndes, Mihály ; Pécsi, Gyula ; Goda, Mária. / Eradication of Helicobacter pylori has no effect on gastric acidity in duodenal ulcer patients - Evaluation of 24-h pH monitoring. In: Journal of Physiology Paris. 2001 ; Vol. 95, No. 1-6. pp. 469-475.
@article{b55cb4706ec14782b3b81161b6a596f3,
title = "Eradication of Helicobacter pylori has no effect on gastric acidity in duodenal ulcer patients - Evaluation of 24-h pH monitoring",
abstract = "It is accepted that eradication of Helicobacter pylori leads to healing of chronic active gastritis facilitates ulcer healing and prevents ulcer recurrence in duodenal ulcer (DU) patients. However, it is not entirely known whether the eradication of the bacteria normalizes gastric acid secretion and abolishes dyspeptic symptoms after ulcer healing. This study was aimed to evaluate the intragastric acidity and dyspeptic complaints before, and 3 months after, eradication in 18 endoscopically proven H. pylori positive DU patients. Gastric pH was measured by 24-h continuous intraluminal recording, serum gastrin measurements and Congo-red tests were also performed. Dyspeptic complaints and antacid consumptions were recorded in diary cards, antisecretory therapy was not allowed after the cessation of eradication therapy. Endoscopy, H. pylori status and Congo-red tests were controlled at the 6th and 12th week, while pH measurements and serum gastrin tests were performed at inclusion and 3 months later. Three patients dropped out and in 14 out of the remaining subjects healing of DUs and successful eradications were achieved by the 6th and 12th week controls. The 24-h median pH and the percentage of 24-h pH readings under pH 3 were not changing significantly by the 3-month controls (from 1.9±0.5 to 1.8±0.4 and from 52.6±5.5{\%} to 58.6±5{\%}, respectively). Similary, no significant changes were observed in serum gastrin levels and dyspeptic symptom scores (from 72±7 pg/ml to 56.7±8 pg/ml and from 2.69±0.4 to 1.26±0.3, respectively). The antacid consumption was almost stable when compared with the pre- and post-eradication periods. It was concluded that despite successful H. pylori eradication and healing of DU, intragastric acidity does not change significantly at least 3 months after the therapy. The persisting dyspeptic symptoms and the need for antacid consumption suggest that some healed ulcer patients require antisecretory therapy in the post-eradication period.",
keywords = "Duodenal ulcer, Dyspeptic symptoms, Eradication therapy, Gastric acidity, Helicobacter pylori",
author = "I. R{\'a}cz and Andrea Szab{\'o} and Mih{\'a}ly Cs{\"o}ndes and Gyula P{\'e}csi and M{\'a}ria Goda",
year = "2001",
doi = "10.1016/S0928-4257(01)00065-1",
language = "English",
volume = "95",
pages = "469--475",
journal = "Journal de Physiologie",
issn = "0928-4257",
publisher = "Elsevier Masson SAS",
number = "1-6",

}

TY - JOUR

T1 - Eradication of Helicobacter pylori has no effect on gastric acidity in duodenal ulcer patients - Evaluation of 24-h pH monitoring

AU - Rácz, I.

AU - Szabó, Andrea

AU - Csöndes, Mihály

AU - Pécsi, Gyula

AU - Goda, Mária

PY - 2001

Y1 - 2001

N2 - It is accepted that eradication of Helicobacter pylori leads to healing of chronic active gastritis facilitates ulcer healing and prevents ulcer recurrence in duodenal ulcer (DU) patients. However, it is not entirely known whether the eradication of the bacteria normalizes gastric acid secretion and abolishes dyspeptic symptoms after ulcer healing. This study was aimed to evaluate the intragastric acidity and dyspeptic complaints before, and 3 months after, eradication in 18 endoscopically proven H. pylori positive DU patients. Gastric pH was measured by 24-h continuous intraluminal recording, serum gastrin measurements and Congo-red tests were also performed. Dyspeptic complaints and antacid consumptions were recorded in diary cards, antisecretory therapy was not allowed after the cessation of eradication therapy. Endoscopy, H. pylori status and Congo-red tests were controlled at the 6th and 12th week, while pH measurements and serum gastrin tests were performed at inclusion and 3 months later. Three patients dropped out and in 14 out of the remaining subjects healing of DUs and successful eradications were achieved by the 6th and 12th week controls. The 24-h median pH and the percentage of 24-h pH readings under pH 3 were not changing significantly by the 3-month controls (from 1.9±0.5 to 1.8±0.4 and from 52.6±5.5% to 58.6±5%, respectively). Similary, no significant changes were observed in serum gastrin levels and dyspeptic symptom scores (from 72±7 pg/ml to 56.7±8 pg/ml and from 2.69±0.4 to 1.26±0.3, respectively). The antacid consumption was almost stable when compared with the pre- and post-eradication periods. It was concluded that despite successful H. pylori eradication and healing of DU, intragastric acidity does not change significantly at least 3 months after the therapy. The persisting dyspeptic symptoms and the need for antacid consumption suggest that some healed ulcer patients require antisecretory therapy in the post-eradication period.

AB - It is accepted that eradication of Helicobacter pylori leads to healing of chronic active gastritis facilitates ulcer healing and prevents ulcer recurrence in duodenal ulcer (DU) patients. However, it is not entirely known whether the eradication of the bacteria normalizes gastric acid secretion and abolishes dyspeptic symptoms after ulcer healing. This study was aimed to evaluate the intragastric acidity and dyspeptic complaints before, and 3 months after, eradication in 18 endoscopically proven H. pylori positive DU patients. Gastric pH was measured by 24-h continuous intraluminal recording, serum gastrin measurements and Congo-red tests were also performed. Dyspeptic complaints and antacid consumptions were recorded in diary cards, antisecretory therapy was not allowed after the cessation of eradication therapy. Endoscopy, H. pylori status and Congo-red tests were controlled at the 6th and 12th week, while pH measurements and serum gastrin tests were performed at inclusion and 3 months later. Three patients dropped out and in 14 out of the remaining subjects healing of DUs and successful eradications were achieved by the 6th and 12th week controls. The 24-h median pH and the percentage of 24-h pH readings under pH 3 were not changing significantly by the 3-month controls (from 1.9±0.5 to 1.8±0.4 and from 52.6±5.5% to 58.6±5%, respectively). Similary, no significant changes were observed in serum gastrin levels and dyspeptic symptom scores (from 72±7 pg/ml to 56.7±8 pg/ml and from 2.69±0.4 to 1.26±0.3, respectively). The antacid consumption was almost stable when compared with the pre- and post-eradication periods. It was concluded that despite successful H. pylori eradication and healing of DU, intragastric acidity does not change significantly at least 3 months after the therapy. The persisting dyspeptic symptoms and the need for antacid consumption suggest that some healed ulcer patients require antisecretory therapy in the post-eradication period.

KW - Duodenal ulcer

KW - Dyspeptic symptoms

KW - Eradication therapy

KW - Gastric acidity

KW - Helicobacter pylori

UR - http://www.scopus.com/inward/record.url?scp=0034751408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034751408&partnerID=8YFLogxK

U2 - 10.1016/S0928-4257(01)00065-1

DO - 10.1016/S0928-4257(01)00065-1

M3 - Article

C2 - 11595477

AN - SCOPUS:0034751408

VL - 95

SP - 469

EP - 475

JO - Journal de Physiologie

JF - Journal de Physiologie

SN - 0928-4257

IS - 1-6

ER -